Apollo Endosurgery, Inc. is revolutionizing the treatment of obesity and other gastrointestinal disorders by developing less invasive solutions for a whole new group of patients not seeking treatment today

from http://apolloendo.com/about-us/

Patents 591show all

  • 294
    A61F - Filters implantable into blood vessels
  • 159
    A61B - Diagnosis
  • 114
    A61M - Devices for introducing media into, or onto, the body
  • 37
    C07K - Peptides
  • 36
    A61K - Preparations for medical, dental, or toilet purposes
  • 29
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 15
    A61L - Methods or apparatus for sterilising materials or objects in general
  • 11
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 10
    A61N - Electrotherapy
  • 8
    F04C - Rotary-piston, or oscillating-piston, positive-displacement machines for liquids

Clinical Trials 11show all

6N/A

SEC Filings show all


6
D

Contact Information

Austin, TX
United States

SEC Form D Funding Events

DateOfferedSoldType
2013-12-16$63,727,392$60,727,392Equity, Option to Acquire, Security to be Acquired, Other
2013-07-03$11,603,494$5,044,998Debt, Option to Acquire, Security to be Acquired, Other
2012-02-10$53,835,471$52,724,242Equity
2009-03-23$3,166,170$3,000,000Debt
2008-03-24Unknown Unknown Other (Paper Filing)

Key Executives

  • Dennis McWilliams
    Executive Officer, Director
  • Matthew Crawford
    Director
  • Bruce Robertson
    Director
  • Matthew S. Crawford
    Director
  • Michael Doty
    Executive Officer
  • John Creecy
    Director
  • Jack Nielsen
    Director
  • R. Kent McGaughy, Jr.
    Director
  • Dennis L McWilliams
    Executive Officer, Director
  • Matthew S Crawford
    Director
  • Michael J Doty
    Executive Officer
  • John W Creecy
    Director
  • Jack B Nielsen
    Director
  • Richard J Meelia
    Director
  • Rick Anderson
    Director